Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,710 | 534 | 62.1% |
| Travel and Lodging | $10,379 | 36 | 27.2% |
| Consulting Fee | $3,885 | 3 | 10.2% |
| Education | $184.25 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $5,109 | 40 | $0 (2019) |
| Abbott Laboratories | $4,263 | 56 | $0 (2024) |
| Medtronic Vascular, Inc. | $3,792 | 24 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $3,330 | 44 | $0 (2024) |
| Medtronic, Inc. | $3,196 | 52 | $0 (2024) |
| Boston Scientific Corporation | $2,341 | 23 | $0 (2023) |
| ShockWave Medical, Inc | $1,899 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,186 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,156 | 57 | $0 (2024) |
| ABIOMED | $1,074 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,286 | 98 | ShockWave Medical, Inc ($1,232) |
| 2023 | $4,047 | 102 | Medtronic, Inc. ($768.83) |
| 2022 | $5,736 | 106 | Bayer HealthCare Pharmaceuticals Inc. ($2,555) |
| 2021 | $5,022 | 101 | Medtronic, Inc. ($1,947) |
| 2020 | $186.57 | 9 | Medtronic Vascular, Inc. ($60.91) |
| 2019 | $4,528 | 41 | Abbott Laboratories ($1,789) |
| 2018 | $5,035 | 50 | Medtronic Vascular, Inc. ($2,057) |
| 2017 | $8,319 | 70 | BIOTRONIK INC. ($4,352) |
All Payment Transactions
577 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $131.32 | General |
| Category: Vascular | ||||||
| 12/24/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $104.57 | General |
| Category: Vascular | ||||||
| 12/18/2024 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Food and Beverage | In-kind items and services | $86.80 | General |
| Category: Vascular | ||||||
| 12/17/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $148.39 | General |
| Category: Lithoplasty | ||||||
| 12/17/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $54.50 | General |
| Category: Cardiovascular Device | ||||||
| 12/14/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $132.58 | General |
| Category: DEVICES | ||||||
| 11/26/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $38.58 | General |
| Category: Lithoplasty | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | AngioDynamics, Inc. | ALPHAVAC (Device) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: VIT | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/06/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Peripheral Intervention | ||||||
| 10/05/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $169.40 | General |
| Category: Lithoplasty | ||||||
| 10/04/2024 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $198.29 | General |
| Category: Peripheral Intervention | ||||||
| 10/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $193.40 | General |
| Category: Lithoplasty | ||||||
| 10/04/2024 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $165.47 | General |
| Category: Peripheral Intervention | ||||||
| 10/04/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $93.44 | General |
| Category: Peripheral Intervention | ||||||
| 10/04/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $40.73 | General |
| Category: Peripheral Intervention | ||||||
| 10/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $40.18 | General |
| Category: Lithoplasty | ||||||
| 10/04/2024 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $39.80 | General |
| Category: Peripheral Intervention | ||||||
| 10/02/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiovascular Diseases | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $120.93 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,005 | 1,388 | $526,401 | $117,601 |
| 2022 | 20 | 812 | 1,085 | $375,353 | $97,415 |
| 2021 | 11 | 257 | 342 | $117,233 | $32,379 |
| 2020 | 14 | 694 | 1,162 | $326,803 | $103,448 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 252 | $83,664 | $23,474 | 28.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 217 | $55,769 | $20,298 | 36.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 89 | 97 | $73,720 | $14,454 | 19.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 71 | 79 | $39,342 | $10,771 | 27.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 56 | $39,648 | $8,661 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $27,755 | $8,277 | 29.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 30 | 31 | $31,000 | $6,338 | 20.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 100 | 104 | $71,955 | $5,465 | 7.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 21 | 21 | $15,645 | $3,296 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 20 | $9,240 | $2,839 | 30.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $8,464 | $2,518 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $6,182 | $1,734 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 112 | 134 | $11,390 | $1,490 | 13.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 19 | 19 | $23,185 | $1,138 | 4.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 21 | 21 | $4,685 | $1,125 | 24.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 12 | 12 | $4,236 | $1,108 | 26.1% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 14 | 14 | $3,766 | $1,104 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $3,978 | $943.06 | 23.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 43 | 53 | $2,120 | $511.45 | 24.1% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 30 | 41 | $1,640 | $450.58 | 27.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 19 | $1,197 | $337.00 | 28.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 17 | $4,384 | $331.50 | 7.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $990.00 | $299.16 | 30.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 23 | 24 | $984.00 | $227.87 | 23.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 19 | 19 | $703.00 | $208.24 | 29.6% |
About Dr. Huseng Vefali, M.D
Dr. Huseng Vefali, M.D is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1083901227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Huseng Vefali, M.D has received a total of $38,158 in payments from pharmaceutical and medical device companies, with $5,286 received in 2024. These payments were reported across 577 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($23,710).
As a Medicare-enrolled provider, Vefali has provided services to 2,768 Medicare beneficiaries, totaling 3,977 services with total Medicare billing of $350,843. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Austin, TX
- Active Since 07/08/2011
- Last Updated 09/03/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083901227
Products in Payments
- Kerendia (Drug) $3,330
- CoreValve Evolut (Device) $1,810
- Mitra Clip system (Device) $1,516
- ClosureFast (Device) $1,450
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $1,232
- ELIQUIS (Drug) $1,217
- Impella (Device) $1,074
- Repatha (Biological) $923.79
- HD-IVUS (Device) $873.00
- ENTRESTO (Drug) $853.47
- ANGIOJET (Device) $851.13
- Indigo System (Device) $671.90
- LifeVest (Device) $614.41
- SC2000 (Device) $599.00
- Reveal LINQ (Device) $579.98
- WATCHMAN (Device) $559.79
- CARTO 3 (Device) $543.50
- VENASEAL (Device) $537.89
- (BH4) IGT Devices Undivided (Device) $533.24
- XARELTO (Drug) $525.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Dr. Jason Zagrodzky, M.d, M.D
Cardiovascular Disease — Payments: $953,600
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Vivek Goswami, Md, MD
Cardiovascular Disease — Payments: $338,027
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010